Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 16:00:17 2024-05-31 EDT 5-day change 1st Jan Change
28.66 USD +1.63% Intraday chart for Pfizer, Inc. -0.76% -0.45%
Sales 2024 * 60.5B 82.47B Sales 2025 * 62.72B 85.48B Capitalization 162B 221B
Net income 2024 * 6.88B 9.38B Net income 2025 * 10.51B 14.33B EV / Sales 2024 * 3.66 x
Net Debt 2024 * 59.14B 80.6B Net Debt 2025 * 54.22B 73.9B EV / Sales 2025 * 3.45 x
P/E ratio 2024 *
21.8 x
P/E ratio 2025 *
14.7 x
Employees 88,000
Yield 2024 *
5.83%
Yield 2025 *
5.94%
Free-Float 59.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.63%
1 week-0.76%
1 month+5.45%
3 months+7.78%
6 months-0.86%
Current year-0.45%
More quotes
1 week
27.69
Extreme 27.69
28.88
1 month
27.32
Extreme 27.32
29.63
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-05-31 28.66 +1.63% 78,290,055
24-05-30 28.2 +1.37% 23,330,710
24-05-29 27.82 -1.70% 24,241,730
24-05-28 28.3 -2.01% 32,371,217
24-05-24 28.88 +0.66% 22,589,127

Delayed Quote Nyse, May 31, 2024 at 04:00 pm

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66 USD
Average target price
31.92 USD
Spread / Average Target
+11.36%
Consensus